Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20824)

• Formulation Name: Temozolomide 140 mg capsule
• Company: Lannett Company

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Temozolomide	(DMKECZD)	Adenocarcinoma	2D40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	(E00007)	222	Alkalizing agent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Tartaric acid	(E00029)	875	Acidulant; Complexing agent; Flavoring agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent